Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Añadir filtros








Intervalo de año
1.
China Pharmacy ; (12): 3036-3041, 2023.
Artículo en Chino | WPRIM | ID: wpr-1003542

RESUMEN

OBJECTIVE To analyze the research status, hotspot and development trend of tyrosine kinase inhibitors (TKIs) in the treatment of human epidermal growth factor receptor 2 (HER2) positive breast cancer. METHODS The literature related to TKIs in the treatment of HER2 positive breast cancer were searched from the Web of Science core collection database; the author, country/region, institution, subject field, journal and keywords was visualized by CiteSpace 6.1.R3 software. RESULTS A total of 732 pieces of literature were included, and the number of literature published showed an increasing trend year by year. The number of literature published in the United States was the largest (center degree 0.10), and the number of literature published in China ranked second (center degree 0.05). The most published and cited authors were Crown from St. Vincent’s University Hospital in Australia and Slamon from University of California, Los Angeles in the United States; the institution with the highest number of literature was the University of Texas MD Anderson Cancer Center, and the journal with the highest number of literature was the Journal of Clinical Oncology. The research mainly focused on five aspects: HER2 positive breast cancer treatment drugs, TKIs receptor, TKIs mechanism of action, HER2 positive breast cancer brain metastasis, and TKIs clinical trials. The main frontier areas and development trends were the combination of TKIs with other drugs or therapies to enhance targeting and reduce toxic side effects. CONCLUSIONS The study of TKIs in the treatment of HER2 positive breast cancer has attracted the attention of scholars at home and abroad. Chinese scholars and research teams need to strengthen cooperation and communication in the future, and cooperation with other countries should be strengthened in terms of the efficacy and safety of TKIs alone and combined with other drugs in the treatment of HER2 positive breast cancer.

2.
China Pharmacy ; (12): 370-375, 2023.
Artículo en Chino | WPRIM | ID: wpr-961675

RESUMEN

OBJECTIVE To quantitatively and qualitatively analyze the progress of potentially inappropriate medication (PIM) research by means of bibliometrics, and to predict the hotspots and trends of PIM, so as to provide reference for PIM research in China. METHODS The research literature related to PIM were searched from Web of Science core database, and the publication trend of the literature was analyzed on the bibliometric online analysis platform and CiteSpace 5.8.R3 software. The research results were visualized and analyzed, and the research hotspots of PIM were summarized through gCLUTO. RESULTS About PIM research, the annual number of the literature issued from 2012 to 2021 showed a continuous growth trend totally; the United States had the largest number of literature (241 pieces); the University of Sydney in Australia was the research institution with the largest number of literature (59 pieces); O’Mahony D from University College Cork, Ireland, published the most literature (23 pieces); the research of PIM involved 57 disciplines, among which there was the largest number of literature about gerontology (384 pieces); International Journal of Clinical Pharmacy was the journal with the largest number of literature (61 pieces); Journal of the American Geriatrics Society was cited most frequently (1 197 times). The hotspots of PIM research mainly focused on seven aspects: the standard of PIM, the safety and economy research of PIM, the risk factors research of PIM, the PIM research of chronic patients, the PIM research of antipsychotics, the research of pharmacists’ participation in PIM management, and the PIM research about palliative care of tumor patients. CONCLUSIONS The heat of research on PIM has been on the rise, and there is little cooperation between countries and institutions, and more cooperation is needed. In the future, the focus of Chinese pharmacists’ research on PIM may be on the deep localization of PIM standards, PIM intervention and precise medication guidance, and PIM management of specific diseases and drugs.

3.
China Pharmacy ; (12): 2649-2653, 2023.
Artículo en Chino | WPRIM | ID: wpr-997801

RESUMEN

OBJECTIVE To establish the index system of quality evaluation standard for pharmacist training in cough and wheeze pharmaceutical care (CWPC) outpatient department, and to provide a basis for the selection of CWPC pharmacist training teachers and the improvement of training plans. METHODS Based on Kirkpatrick model, using the Delphi method, a total of 15 experts from 13 tertiary hospitals in 10 provinces in China were consulted to establish the standard index system of the quality evaluation for CWPC pharmacists training. Analytic hierarchy process (AHP) was adopted to determine the weights of each indicator and quantify the index system according to the weights of indicators at all levels. RESULTS The coefficient of expert authority was 0.810, the judgment coefficient was 0.727, and the familiarity coefficient was 0.893. The Kendall coordination coefficient of each index was 0.308-0.687. The P values of χ2 test were all less than 0.05, which indicated that the degree of coordination of the experts was high. After two rounds of correspondence, Kirkpatrick model-based index system of quality evaluation standard for CWPC pharmacist training was determined. The index system included 4 first-level indexes (participants’ reaction layer, learning gain layer, behavior improvement layer, training outcome layer), 12 second-level indexes (such as training needs, teaching methods, theoretical knowledge, practical skills, job abilities, patient benefits, etc.) and 44 third-level indexes (such as clear training objectives, core system of CWPC, special device operation and evaluation, professional knowledge related to the treatment of cough and wheeze patients, promoting the construction of CWPC, improving patient compliance). CONCLUSIONS The constructed index system of quality evaluation standard for CWPC pharmacist training has a certain level of authority and scientificity, and provides a scientific theoretical basis for quality evaluation of CWPC pharmacist training.

4.
China Pharmacy ; (12): 242-245, 2023.
Artículo en Chino | WPRIM | ID: wpr-959756

RESUMEN

OBJECTIVE To construct the evaluation index system for scientific research ability of hospital pharmacists, and provide reference for the improvement of hospital pharmacists’ scientific research ability and the formulation of relevant scientific research policies. METHODS The relevant indexes of scientific research evaluation of hospital pharmacists were extracted by literature analysis, and consultation questionnaire was designed according to Likert grade 5 scoring method. Delphi method was used to conduct two rounds of questionnaire consultation for 28 experts, and the weight of each index was determined by analytic hierarchy process. The reliability and validity of index system were analyzed by questionnaire survey. RESULTS After two rounds of expert correspondence, evaluation index system for scientific research ability of hospital pharmacists was finally determined from three core dimensions: basic scientific research ability, scientific research achievements and transformation ability, academic influence and personnel training (including 11 sub-dimensions and 34 measurement items). The weight value of each dimension index was determined. The result of reliability and validity analysis confirmed the scientific rationality of the index system. CONCLUSIONS The established evaluation index system for scientific research ability of hospital pharmacists is innovative, comprehensive and scientific. The index system model can provide reference for the improvement of hospital pharmacists’ scientific research ability and the formulation of relevant scientific research policies.

5.
China Pharmacy ; (12): 849-853, 2023.
Artículo en Chino | WPRIM | ID: wpr-969583

RESUMEN

OBJECTIVE To investigate the clinical efficacy and safety of rituximab (RTX) followed by belimumab (BLM) in patients with severe systemic lupus erythematosus(SSLE). METHODS Nine SSLE patients, who were treated with RTX followed by BLM for more than 6 months in the Department of Rheumatology and Immunology of the First Affiliated Hospital of Zhengzhou University from October 2020 to June 2021, were enrolled. Baseline clinical data of patients, laboratory examination results and basic treatment status at weeks 0, 4, 12, and 24 of medication were collected retrospectively. The patients’ systemic lupus erythematosus disease activity index (SLEDAI) score, glucocorticoid dosage and serological indicators (complement C3, complement C4, serum albumin, and 24-hour urine protein quantification) level were analyzed. At the same time, the occurrence of adverse drug reaction was collected. RESULTS All 9 patients completed more than 24 weeks of RTX followed by BLM therapy. All patients suffered from renal impairment, of which 7 (77.8%) had renal pathology support, 3(33.3%) had blood system damage and 2 (22.2%) had nervous system damage. During treatment, with the prolongation of treatment time, the SLEDAI score, 24- hour urinary protein quantification, and glucocorticoid dosage of patients showed a significant downward trend, and ultimately decreased to the normal index level (P<0.05); serum albumin, complement C3 and complement C4 all showed a significant upward trend, eventually rose to the normal index level (P<0.05). During treatment and follow-up, 1 patient developed herpes zoster, 1 patient developed upper respiratory tract virus infection, and 1 patient developed urinary system bacterial infection. All patients recovered after symptomatic treatment. CONCLUSIONS In sequential use of RTX followed by BLM for SSLE, early administration of RTX can quickly stabilizethe condition, significantly alleviate clinical symptoms, and gradually normalize specific serological indicators; subsequent administration of BLM can reduce the type and dosage of basic treatment drugs; there is no increase in the incidence of adverse drug reactions.

6.
China Pharmacy ; (12): 1492-1499, 2022.
Artículo en Chino | WPRIM | ID: wpr-927198

RESUMEN

OBJECTIVE To systema tically evaluate the efficacy and safety of blinatumomab for acute lymphoblastic leukemia (ALL)in order to provide evidence-based reference for clinical use. METHODS Retrieved from PubMed ,Embase,Web of Science,the Cochrane Library ,CNKI,Wanfang database and CBM during the inception to February 3,2022,randomized controlled trials (RCTs)and cohort studies of blinatumomab (experimental group ) versus conventional chemotherapy (control group )in the treatment of ALL were collected. After literature screening and data extraction ,the quality of RCTs was evaluated by the risk bias evaluation tool recommended by Cochrane handbook 5.1.0,and the quality of cohort studies was evaluated by the Newcastle-Ottawa scale (NOS). Meta-analysis was performed by RevMan 5.4 software. GRADE grading system was used to evaluate the evidence quality of outcomes. The publication bias was analyzed by inverted funnel plot. RESULTS A total of 8 studies were included ,involving 3 RCTs and 5 cohort studies ,with a total of 2 841 patients. Results of Meta-analysis showed that the overall survival rate more than one year [RR =1.30,95%CI(1.14,1.48),P<0.000 1],relapse-free survival rate [RR =1.78,95%CI(1.50,2.12),P<0.000 01],complete remission rate [RR =1.42,95%CI(1.11,1.82),P=0.006],the incidence of tremor [RR =16.98,95%CI(2.17,133.12),P=0.007],and the incidence of cytokine release syndrome [RR =14.11, 95%CI(3.43,58.01),P=0.000 2] in trial group were all significantly higher than control group ,but there was no statistical significance in the incidence of headache between two groups [RR =1.31,95%CI(0.66,2.59),P=0.44]. The incidence of adverse events with grade more than or equal to 3,infection,stomatitis,thrombocytopenia,febrile neutropenia ,anorexia, constipation,diarrhea,abdominal pain ,hypokalemia in trial group were significantly lower than control group (P<0.05). The incidence of cough ,rash and hypogamma globulinemia and fever in the trial group were significantly higher than control group (P<0.05). There was no statistical significance in the total incidence of adverse events ,sepsis,anemia,leucopenia,neutropenia, lymphopenia,nausea,vomiting,hyperglycemia,hypotension,hypertension,elevated transaminase or epistaxis between two groups(P>0.05). Results of subgroup analysis by study type showed that the overall survival rate ,relapse-free survival rate and complete response rate (except for cohort studies )of patients in trial group were significantly higher than control group in both RCTs and cohort studies (P<0.05). The results of GRADE evaluation showed that the overall quality of index evidence included in this study was low. There was little possibility of publication bias in this study based on the publication bias analysis. CONCLUSIONS Blinatumomab is effective in the treatment of ALL ,with low incidence of infection and adverse events of digestive system ,but high incidence of tremor ,cough,rash,fever,hypoproglobulinemia and cytokine release syndrome. The evidence quality of the indicators included in this study is generally low .

7.
China Pharmacy ; (12): 366-371, 2022.
Artículo en Chino | WPRIM | ID: wpr-913097

RESUMEN

OBJECTIVE To investigate the situation ,influential factors and their re lationship of hospital pharmacy managers ’ servant leadership behavior and hospital pharmacists ’job satisfaction. METHODS The questionnaire survey method was adopted to stratified cluster sampling from primary ,secondary and tertiary hospitals ,five for each in Henan province. The personal basic data scale of pharmacists ,the hospital pharmaceutical service leadership behavior scale and the job satisfaction scale of pharmacists were used to conduct a questionnaire survey among hospital pharmacists. Excel 2019 and SPSS 23.0 software were used for statistical analysis. RESULTS A total of 956 questionnaires were distributed and 882 questionnaires were recovered ,including 841 valid questionnaires,with an effective recovery rate of 95.35%. The reliability coefficients Cronbach’s α of hospital pharmacy managers ’ servant leadership behavior scale and hospital pharmacists ’job satisfaction scale were 0.986 and 0.978,and the validity coefficients KMO were 0.908 and 0.977(P<0.01). The total score of hospital pharmacy managers ’servant leadership behavior was (110.73± 18.63). The total score of hospital pharmacists ’job satisfaction was (126.33±17.79). Hospital grade ,gender,age,professional title and highest education level all affected pharmacists ’recognition for managers ’servant leadership behavior (P<0.05). Hospital grade,age,professional title ,marital status ,highest education level and position all affected job satisfaction (P<0.05). The servant leadership behavior of hospital pharmacy managers was positively correlated with the job satisfaction of hospital pharmacists (correlation coefficient r was 0.521-0.698,all P<0.01). CONCLUSIONS The promotion and optimization the servant leadership behavior of hospital pharmacy managers can improve the job satisfaction of pharmacists ,stabilize the team of pharmacists ,and provide high-quality pharmaceutical care for patients ,so as to improve the core competitiveness of the hospital.

8.
China Pharmacy ; (12): 996-1002, 2022.
Artículo en Chino | WPRIM | ID: wpr-923605

RESUMEN

OBJECTIVE To analyze the si tuation and hot spots of gabapentinoid drugs in the treatment of pain. METHODS Related researches about gabapentinoid drugs in the treatment of pain were retrieved from Web of Science core collection database during Jan. 1st,2011-Dec. 31st,2020. VOSviewer 1.6.17,CiteSpace 5.8.R1 and Excel 2018 software were used to statistically analyze the key characteristics of relevant literature ,such as the annual publications ,countries/regions,institutions,authors, journals and research hot spots. RESULTS & CONCLUSIONS A total of 3 519 literatures were retrieved ,and the annual publication outputs showed an upward trend generally. Totally 86 countries/regions had conducted relevant studies ,of which the United States ranked first (up to 1 219),and had close cooperation with the United Kingdom ,Canada,China,Germany,Japan, etc;a total of 3 996 institutions had published relevant literatures ,and the Pfizer Inc. issued the most publications ;the most studies were devoted by Professor Parsons from the University of California San Diego ,and the highest co-citations author was Professor Gilron from the Queen ’s University. Among 1 185 journals,Pain ranked first not only in the high-productive journal ,but also in the co-cited journal. The main hot topics include abuse and misuse of gabapentinoid ,off-label use of gabapentinoid ,clinical application of gabapentinoid as a component of multimodal analgesia ,and the update of guidelines for pain based on systematic evaluation and meta-analysis.

9.
Cancer Research on Prevention and Treatment ; (12): 963-969, 2021.
Artículo en Chino | WPRIM | ID: wpr-988479

RESUMEN

Objective To compare the research status and hotspots of immunotherapy for liver cancer at home and abroad. Methods Papers about immunotherapy for liver cancer published from the establishment to 2019 were searched in PubMed database and Chinese database. Information were extracted and sorted by BICOMB-2 software, and then we created the word matrix and co-occurrence matrix of high-frequency subject headings. The cluster analysis of subject headings was conducted by gCLUTO 1.0. NetDraw 2.089 was used to draw social network diagrams, UCINET 6.212 was used to conduct the centrality analysis. Results There were 2 081 foreign literatures and 901 Chinese literatures, involving 655 foreign periodicals and 275 Chinese periodicals. Four themes of immunotherapy for liver cancer were determined: the correlation between the immune inoculation of hepatitis B patients and the occurrence of liver cancer, the study between dendritic cells and immunotherapy for liver cancer, the study of the combination of radiotherapy and immunotherapy on liver cancer, and related research of natural killer cells and liver cancer immunotherapy. Conclusion The number of researches on immunotherapy for liver cancer have shown an increasing trend year by year. We can learn from the international research status and hotspots to create a new way for liver cancer treatment.

10.
China Pharmacy ; (12): 1818-1824, 2021.
Artículo en Chino | WPRIM | ID: wpr-886273

RESUMEN

OBJECTIVE:To study the research status ,hotspots and frontier cha nges of drug-induced kidney injury (DIKI), and to provide reference for the research of DIKI in China. METHODS :Literatures related to DIKI published from 2001 to 2020 were retrieved from Web of Science database. CiteSpace 5.7.R2 software was used to conduct visualization analysis for DIKI related literatures from aspects of the number of publications ,authors and cited authors ,institutions,countries,related disciplines , co-cited journals ,co-cited literatures and keywords. RESULTS :A total of 1 320 literatures were included ,and the number of published literatures about DIKI researches showed an upward trend during 2001-2020. The most studies and the highest co-citations were devoted by the Yale University scholar Mark A Perazella (18 literatures,cited for 137 times). There were 76 countries carrying out research in this field ,among which the United States had the first advantage (445 literatures,accounting for 34.29% of the total number of literatures ). A total of 2 175 institutions participated in this field ,of which Yale University contributed the most publications ;pharmacology,nephrology,toxicology and other related disciplines were involved in this field ;Kidney International(652 literatures,USA)published the most research in this field ;the most frequently cited literature was “Drug- induced nephrotoxicity :clinical impact and preclinical in vitro models ”,published by Tiong et al in 2014. Through the keyword cluster analysis ,the research hotspots in this field mainly focused on the risk factors of DIKI ,the research of DIKI in special groups,the mechanism of DIKI related drugs ,the exploration of DIKI biomarkers ,and the preclinical research of DIKI. CONCLUSIONS:DIKI’s research has been paid more and more attention by scholars ,but the cooperation between China and other countries in this field is limited. In the future ,more attention should be paid to the research hotspot in this field and international exchanges and cooperation should be strengthened.

11.
China Pharmacy ; (12): 1622-1627, 2020.
Artículo en Chino | WPRIM | ID: wpr-822630

RESUMEN

OBJECTIVE:To investigate the research status and hotspots of inhalation therapy for respiratory diseases in the world,and to provide reference for further development of the filed in China. METHODS :All literatures about inhalation therapy for respiratory disease were retrieved from Web of Science database from the inception to Jan. 1st,2020. The retrieval result analysis function of Web of Science combined with visual analysis function of CiteSpace 5.1.R6SE software were used to analyze included literatures from respective of annual number of articles published ,countries,institutions,categories and co-cited authors , so as to analyze the research situation in this field. The knowledge map of key words was drawn ,then cluster analysis and burst detection were carried out ,and the research hotspot and development process were analyzed. RESULTS :A total of 1 385 literatures were included. From 1947 to 2020,the overall trend of annual number of articles published was on the rise. There were 66 countries involved in relevant research ,the United States was in the leading position (the number of articles published accounting for 33.79% of total articles published ),followed by Germany and UK (the number of articles published accounting for 10.32%, 8.88% of total articles published ),while Chinese number of articles published accounting for only 3.75% of total articles published. Institutions involved in this research field included the respiratory diseases research institution ,comprehensive universities and national institute for occupational safety health ;top ranked institutions were Sydney University ,North Carolina University, Harvard University , etc. The subject category involved molecular biology , internal medicine , pharmacology, engineering and other fields. A total of 749 authors were co-cited ,and the co-cited frequency of top two authors were 109,84 times respectively. Through the cluster analysis ,6 major researches hotspots were obtained in this field ,including the dosage form and technology design of inhaled drugs ,the mechanism of inhaled drugs ,the application of inhalation therapy for the obstructive diseases of respiratory system ,the application of inhalation therapy for the infectious diseases of respiratory system ,the application of inhalation therapy for the special population of respiratory diseases,and the risk factors in the application of inhalation (No.2017YFC0909900) therapy for respiratory diseases. Through the sudden detection , it was found that in the early 1990s,the research in this field was very active ,and there were many research hotspots ;in the early 21st century , there were several new research hotspots for a short time ,such as metered-dose inhaler ,aerosol,etc.;till the 2020s,there were many research hotspots ,such as nanoparticles,human trials ,etc. CONCLUSIONS :Researches about inhalation therapy for the respiratory diseases are steadily increasing internationally ,while the researches in this field in China is still very limited. In the future ,our country can pay attention to the international research hotspot and direction in this field ,and further strengthen the exchanges and cooperation with other countries.

12.
Chinese Journal of Applied Clinical Pediatrics ; (24): 1757-1760, 2020.
Artículo en Chino | WPRIM | ID: wpr-864312

RESUMEN

Fluoroquinolones are widely used in clinical practice, but their clinical application in juvenile patients has been controversial.The purpose of this study was to investigate the pharmacokinetic characteristics, indications and adverse reactions of Ciprofloxacin and Levofloxacin in minors.It is shown that the two drugs are effective for infectious diseases and no serious or persistent joint or skeletal muscle injury occurs in minors using the drugs.Hence, in the absence of alternatives, the benefits of Ciprofloxacin or Levofloxacin treatment for minors may outweigh the risks.

13.
China Pharmacy ; (12): 865-868, 2020.
Artículo en Chino | WPRIM | ID: wpr-819102

RESUMEN

OBJECTIVE:To establis h the evaluation model of hospital pharmacist post value of dispensing department ,and to provide scientific basis for optimizing the performance management of pharmacists in despensing department in hospital. METHODS:Based on factor counting method ,combined with questionnaire ,Delphi expert correspondence method and so on ,the hospital pharmacist post value evaluation model was established. Based on this ,the relative value scores of the pharmacists in the dispensing department was determined. RESULTS :Hospital pharmacist post value evaluation model was established with 5 evaluation dimensions (knowledge,skills,responsibility,work autonomy ,work environment and intensity ,of which the first level weight coefficients were 0.194,0.166,0.365,0.216 and 0.058,respectively)and 31 evaluation elements. The above 5 evaluation dimensions contained 5,8,9,3,6 evaluation elements ,respectively,and the corresponding second-level weights were 0.052-0.431 (for example ,responsibility dimension with the highest weight ,including quality and safety control ,decision responsibility,responsibility for finance and assets ,the corresponding second-level weight coefficients were 0.279,0.140,0.132, respectively). The relative value scores of 13 pharmacist post were 342.9-840.4 in the dispensing department of our hospital with this model ,among which the department responsible person had the highest score (840.4)and the prescription post score was the lowest(342.9). CONCLUSIONS :The hospital pharmacist post value evaluation model constructed by factor counting method can provide a scientific and reliable theoretical basis for realizing the rewards of different positions in the dispensing department.

14.
China Pharmacy ; (12): 1014-1018, 2018.
Artículo en Chino | WPRIM | ID: wpr-704726

RESUMEN

OBJECTIVE:To investigate the situation and influential factors of hospital pharmacist career planning and career satisfaction and their relationship. METHODS:The questionnaire modified according to"general career planning and career satisfaction scale"was adopted for questionnaire survey among pharmacists in 5 third grade class A hospitals by simple random sampling. The factor analysis was used to test the reliability and validity of the questionnaire. The influential factors of career planning and satisfaction degree,the relationship of career planning with satisfaction degree were analyzed by multiple regression analysis and Spearman correlation coefficient. RESULTS:Totally 210 questionnaires were sent out and 198 were effectively received,with effective recovery of 94.28%. Cronbach'α value of reliability and validity test was 0.939(>0.6),and KMO value was 0.905(close to 1). Results of survey showed that there was statistical significance in the effects of gender,age,marital status, work experience,professional title and position on career planning(P<0.05). There was statistical significance in the effects of age and professional title on satisfaction degree(P<0.05). Different dimensions of career planning(self-assessment,career awareness and action,position questions)were positively correlated with career satisfaction degree(total correlation coefficients were 0.649,0.633,0.694). CONCLUSIONS:Career planning is mainly influenced by gender,age,marital status,work experience,professional title and position. Career satisfaction degree is greatly influenced by age and position.The better the career planning is,the higher the satisfaction is. It is suggested to conduct professional training of hospital pharmacists by referring to the theory and experience of management,help pharmacists to fully understand the job responsibilities and do a good job in the position of professional roles. The establishment of scientific and effective career planning management system improves self-management ability of hospital pharmacists and career satisfaction degree,and promotes the development of discipline.

15.
China Pharmacy ; (12): 25-28, 2018.
Artículo en Chino | WPRIM | ID: wpr-704511

RESUMEN

OBJECTIVE:To reduce drug repercussion of outpatient pharmacy,and to promote safe drug use.METHODS:By quality control circle (QCC),the data of drug repercussion were selected from outpatient pharmacy of our hospital in Sept.2016.The drug repercussion reason check list was designed to master the situation of drug repercussion in outpatient department,formulate improvement measures and confirm effect through field inspection.The case number of drug repercussion and the improvement of circle members' ability were compared one month before and after QCC (Mar.2017).Finally,the effects of QCC were evaluated.RESULTS:Referring to the reasons for the repercussion of adjunct drugs for inspection and the repercussion of unsuitable drug use in our hospital,those problems were improved by formulating manual for drug use examination project,optimizing and examining drug delivery process in the department,etc.The case number of drug repercussion in outpatient pharmacy decreased from 31 cases per month to 12 cases per month;the rate of goal achievement was 119%;the rate of improvement was 61%.The ability of QCC members to solve problems and the ability to use QCC skills were increased positively.CONCLUSIONS:The development of QCC activity in our hospital reduces case number of drug repercussion and optimizes drug delivery process in outpatient pharmacy,and promotes safe drug use.

16.
China Pharmacy ; (12): 1884-1888, 2017.
Artículo en Chino | WPRIM | ID: wpr-607975

RESUMEN

OBJECTIVE:To provide reference for standardized management of skin test of cephalosporin injection in our hos-pital. METHODS:In retrospective analysis,skin test of 8 kinds of cephalosporin [cefotaxime(1.0 g),cefotaxime(0.5 g),cefoti-am (1.0 g),cefotiam (0.5 g),ceftazidime (0.5 g),cefminox (0.5 g),cefminox (1.0 g),ceftriaxone (1.0 g)] and the cost of skin test, related cost of allergic reaction induced by cephalosporin injection were analyzed statistically during Sept. 1st, 2015-Aug. 31th,2016. The cost of skin test of cephalosporin injection was compared with allergic reaction cost reduced by skin test. RESULTS:The positive rate of 100330 patients who used above 8 kinds of cephalosporin injections was 6.27%;the rate of skin test was 82.49%;the direct cost of skin test was 3434411.72 yuan;the indirect cost was 141985.12 yuan;the cost of pa-tient was 3162901.44 yuan;the cost of medical insurance was 259096.28 yuan;the cost of the whole society was 3576396.84 yuan. From the perspective of the whole society,the cost of skin test of cephalosporin injections was(447049.61±247395.07)yuan, and allergic reaction cost reduced by skin test was (316075.48 ± 260600.49)yuan. The cost of skin test was significantly higher than allergic reaction cost reduced by skin test,with statistical significance(P<0.05). CONCLUSIONS:Skin test of cephalosporin injection is low in positive rate,has high expense. The government standardizes the management of skin test of cephalosporin injec-tion and reduces the economic burden of patients under the premise of ensuring the safety of drug use.

17.
China Pharmacy ; (12): 1023-1026, 2017.
Artículo en Chino | WPRIM | ID: wpr-514938

RESUMEN

OBJECTIVE:To measure and analysis the related costs of drug-induced liver injury (D1LI) from different decision makers,and to provide reference for reducing related costs of DILI,improving medical insurance system and realizing effective health resource distribution.METHODS:In retrospective study,60 cured or recovered DILI inpatieuts were randomly selected as subjects from medical record management system of 4 hospitals in Henan province during Jun.2014-Jun.2015.Demographic character istic,clinical characteristic and related cost of DILI were analyzed retrospectively and the cost structure was also analyzed from different decison makers (patient,society,medical insurance payer).RESULTS:The total direct medical cost of 60 cases was 584 113.05 yuan,and total direct non-medical cost was 31 093.15 yuan and total indirect cost was 169 379.95 yuan.The total cost of DILI of fered by patients was 616 296.38 yuan;the total cost of DILI offered by society was 784 586.15 yuan;the total cost of DILI offered by medical insurance was 168 289.77 yuan.CONCLUSIONS:DILI results in serious economic damage for patients and society,deserving attracting extensive attention worldwide.The study provide reference for reducing patient's medical burden and improving medical insurance system,and contribute to optimize medical resource distribution.

18.
Chinese Traditional Patent Medicine ; (12): 1183-1187, 2017.
Artículo en Chino | WPRIM | ID: wpr-617857

RESUMEN

AIM To establish an ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the simultaneous content determination of gallic acid,matrine,danshensu,hydroxysafflor yellow A,caffeic acid,paeoniflorin,ferulic acid and cynaroside in Xuebijing Injection (Carthami Flos,Paeoniae Radix Rubra,Chuanxiong Rhizoma,etc.).METHODS The analysis of 5% acetonitrile extract of this drug was performed on a 40 ℃ thermostatic ACQUITY UPLC(C) BEH C18 column (2.1 mm × 50 mm,1.8 μm),with the mobile phase comprising of acetonitrile-0.1% formic acid flowing at 0.2 mL/min in a gradient elution manner,after which cluster analysis was applied to the determined contents.RESULTS Eight constituents showed good linear relationships within their own ranges (r > 0.996 0),whose average recoveries were 95%-104% with the RSDs of less than 3%.Generally the contents of various constituents in ten batches of samples were found to be stable except the certain differences contributed by gallic acid and paeoniflorin.CONCLUSION We should pay attention to the quality of different batches of Xuebijing Injection due to their uneven performance.

19.
Chinese Journal of General Surgery ; (12): 620-622, 2014.
Artículo en Chino | WPRIM | ID: wpr-457136

RESUMEN

Objective To investigate the clinical characteristics and summarize the experiences on the diagnosis and treatment of gastritis cystica profunda (GCP).Methods Clinical data of 15 GCP patients,who were treated in the First and Second Affiliated Hospital of Zhengzhou University from January 2006 to January 2013,were retrospectively analyzed.Results GCP may present clinically as abdominal pain,bloating,emaciation,and GI bleeding.CT,electronic gastroscope,or ultrasonic endoscope shows that GCP consists of multiple cysts within a thickened submucosal layer.The submucosal pathological features can not be obtained by ordinary biopsy and snares.Of the 15 cases,proximal gastrectomy was performed in 4 cases,distal subtotal gastrectomy in 3 cases,1 case was treated with gastric wedge resection,and total gastrectomy was performed in 7 cases.Postoperative recovery was uneventful.13 cases were followed up for 2 years,and there was no evidence of recurrence.Conclusions GCP is an uncommon disease with unknown origin,and has no clinical characteristics,and has malignant potential.Postoperative prognosis is satisfactory.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA